{"title":"肠外注射氨基酸降低吸入性肺炎空腹患者的急性死亡率:一项回顾性研究。","authors":"Takashi Ogasawara , Yuki Hiraoka , Natsuko Hosoya , Masayuki Sugiura , Ei Kishimoto , Kimihiko Nagasaki , Wataru Matsuyama , Takahito Suzuki , Mitsuru Niwa , Yuichi Ozawa , Masahito Ogiku , Jun Sato","doi":"10.1016/j.clnesp.2025.01.054","DOIUrl":null,"url":null,"abstract":"<div><h3>Background & aims</h3><div>To prevent food aspiration, numerous patients with aspiration pneumonia are restricted from eating early during their hospital stay. Although they receive parenteral nutrition (PN) on a fasting regimen, the optimal dose and composition remain unknown. The current study aimed to investigate whether PN with amino acids (AA) affects 30-day mortality of patients with aspiration pneumonia.</div></div><div><h3>Methods</h3><div>This retrospective study included 115 patients with aspiration pneumonia who were admitted to our hospital between November 2019 and November 2023. All patients followed the clinical pathway for aspiration pneumonia, had been fasting for >5 days, and received PN alone on admission. Given that treating physicians could modify the standard PN regimen by including AA, some patients received maintenance infusion without AA. The patients were divided in those who received PN with AA (>15 g/day, AA group) and those who did not (0–15 g/day, non-amino acid [NAA] group). The primary endpoint was 30-day in-hospital mortality.</div></div><div><h3>Results</h3><div>Among the 115 patients, 65 (57 %) received PN with AA from days 2–5. No significant differences in background characteristics and severity of pneumonia were observed, except for heart failure. Serum albumin levels were significantly lower in the AA group than in the NAA group (median, 2.9 vs. 3.2 g/dL; P = 0.003). Median energy intake on days 2 and 5 were significantly higher in the AA group than in the NAA group (day 2: 10.7 vs. 3.7 kcal/kg/day; day 5: 10.6 vs. 4.2 kcal/kg/day, respectively). The AA group had a median protein dose of 0.76 and 0.74 g/kg/day on days 2 and 5, respectively, whereas the NAA group had a median protein dose of 0.00 g/kg/day on both days. After adjusting for age, sex, body mass index, albumin, and pneumonia severity, 30-day in-hospital mortality was lower in the AA group than in the NAA group (hazard ratio, 0.31; 95 % confidence interval, 0.10–0.99).</div></div><div><h3>Conclusions</h3><div>Early PN with AA may play an important role in improving 30-day in-hospital mortality among fasting patients with aspiration pneumonia after hospital admission.</div></div>","PeriodicalId":10352,"journal":{"name":"Clinical nutrition ESPEN","volume":"66 ","pages":"Pages 221-225"},"PeriodicalIF":2.6000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Parenterally administered amino acids decrease acute mortality in fasting patients with aspiration pneumonia: A retrospective study\",\"authors\":\"Takashi Ogasawara , Yuki Hiraoka , Natsuko Hosoya , Masayuki Sugiura , Ei Kishimoto , Kimihiko Nagasaki , Wataru Matsuyama , Takahito Suzuki , Mitsuru Niwa , Yuichi Ozawa , Masahito Ogiku , Jun Sato\",\"doi\":\"10.1016/j.clnesp.2025.01.054\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background & aims</h3><div>To prevent food aspiration, numerous patients with aspiration pneumonia are restricted from eating early during their hospital stay. Although they receive parenteral nutrition (PN) on a fasting regimen, the optimal dose and composition remain unknown. The current study aimed to investigate whether PN with amino acids (AA) affects 30-day mortality of patients with aspiration pneumonia.</div></div><div><h3>Methods</h3><div>This retrospective study included 115 patients with aspiration pneumonia who were admitted to our hospital between November 2019 and November 2023. All patients followed the clinical pathway for aspiration pneumonia, had been fasting for >5 days, and received PN alone on admission. Given that treating physicians could modify the standard PN regimen by including AA, some patients received maintenance infusion without AA. The patients were divided in those who received PN with AA (>15 g/day, AA group) and those who did not (0–15 g/day, non-amino acid [NAA] group). The primary endpoint was 30-day in-hospital mortality.</div></div><div><h3>Results</h3><div>Among the 115 patients, 65 (57 %) received PN with AA from days 2–5. No significant differences in background characteristics and severity of pneumonia were observed, except for heart failure. Serum albumin levels were significantly lower in the AA group than in the NAA group (median, 2.9 vs. 3.2 g/dL; P = 0.003). Median energy intake on days 2 and 5 were significantly higher in the AA group than in the NAA group (day 2: 10.7 vs. 3.7 kcal/kg/day; day 5: 10.6 vs. 4.2 kcal/kg/day, respectively). The AA group had a median protein dose of 0.76 and 0.74 g/kg/day on days 2 and 5, respectively, whereas the NAA group had a median protein dose of 0.00 g/kg/day on both days. After adjusting for age, sex, body mass index, albumin, and pneumonia severity, 30-day in-hospital mortality was lower in the AA group than in the NAA group (hazard ratio, 0.31; 95 % confidence interval, 0.10–0.99).</div></div><div><h3>Conclusions</h3><div>Early PN with AA may play an important role in improving 30-day in-hospital mortality among fasting patients with aspiration pneumonia after hospital admission.</div></div>\",\"PeriodicalId\":10352,\"journal\":{\"name\":\"Clinical nutrition ESPEN\",\"volume\":\"66 \",\"pages\":\"Pages 221-225\"},\"PeriodicalIF\":2.6000,\"publicationDate\":\"2025-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical nutrition ESPEN\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2405457725000555\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/28 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"NUTRITION & DIETETICS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical nutrition ESPEN","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2405457725000555","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/28 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"NUTRITION & DIETETICS","Score":null,"Total":0}
引用次数: 0
摘要
背景与目的:为了防止食物误吸,许多吸入性肺炎患者在住院期间早期被限制进食。虽然他们在禁食方案中接受肠外营养(PN),但最佳剂量和成分仍然未知。本研究旨在探讨氨基酸(AA) PN是否影响吸入性肺炎患者30天死亡率。方法:回顾性研究纳入2019年11月至2023年11月我院收治的115例吸入性肺炎患者。所有患者均遵循吸入性肺炎的临床路径,禁食50天,入院时单独接受PN治疗。考虑到治疗医生可以通过加入AA来修改标准PN方案,一些患者接受不加AA的维持性输注。将患者分为PN联合AA组(> -15 g/d, AA组)和未联合AA组(0-15 g/d,非氨基酸[NAA]组)。主要终点为30天住院死亡率。结果:115例患者中,65例(57%)在第2天至第5天接受PN + AA治疗。除心力衰竭外,肺炎的背景特征和严重程度无显著差异。AA组血清白蛋白水平显著低于NAA组(中位数,2.9 g/dL vs. 3.2 g/dL;P = 0.003)。第2天和第5天,AA组的平均能量摄入显著高于NAA组(第2天:10.7 vs 3.7 kcal/kg/day;第5天:分别为10.6和4.2千卡/公斤/天)。AA组在第2天和第5天的蛋白质中位剂量分别为0.76和0.74 g/kg/d,而NAA组在第2天和第5天的蛋白质中位剂量均为0.00 g/kg/d。在调整了年龄、性别、体重指数、白蛋白和肺炎严重程度后,AA组30天住院死亡率低于NAA组(风险比,0.31;95%置信区间0.10-0.99)。结论:早期PN合并AA可能对提高吸入性肺炎空腹患者入院后30天住院死亡率有重要作用。
Parenterally administered amino acids decrease acute mortality in fasting patients with aspiration pneumonia: A retrospective study
Background & aims
To prevent food aspiration, numerous patients with aspiration pneumonia are restricted from eating early during their hospital stay. Although they receive parenteral nutrition (PN) on a fasting regimen, the optimal dose and composition remain unknown. The current study aimed to investigate whether PN with amino acids (AA) affects 30-day mortality of patients with aspiration pneumonia.
Methods
This retrospective study included 115 patients with aspiration pneumonia who were admitted to our hospital between November 2019 and November 2023. All patients followed the clinical pathway for aspiration pneumonia, had been fasting for >5 days, and received PN alone on admission. Given that treating physicians could modify the standard PN regimen by including AA, some patients received maintenance infusion without AA. The patients were divided in those who received PN with AA (>15 g/day, AA group) and those who did not (0–15 g/day, non-amino acid [NAA] group). The primary endpoint was 30-day in-hospital mortality.
Results
Among the 115 patients, 65 (57 %) received PN with AA from days 2–5. No significant differences in background characteristics and severity of pneumonia were observed, except for heart failure. Serum albumin levels were significantly lower in the AA group than in the NAA group (median, 2.9 vs. 3.2 g/dL; P = 0.003). Median energy intake on days 2 and 5 were significantly higher in the AA group than in the NAA group (day 2: 10.7 vs. 3.7 kcal/kg/day; day 5: 10.6 vs. 4.2 kcal/kg/day, respectively). The AA group had a median protein dose of 0.76 and 0.74 g/kg/day on days 2 and 5, respectively, whereas the NAA group had a median protein dose of 0.00 g/kg/day on both days. After adjusting for age, sex, body mass index, albumin, and pneumonia severity, 30-day in-hospital mortality was lower in the AA group than in the NAA group (hazard ratio, 0.31; 95 % confidence interval, 0.10–0.99).
Conclusions
Early PN with AA may play an important role in improving 30-day in-hospital mortality among fasting patients with aspiration pneumonia after hospital admission.
期刊介绍:
Clinical Nutrition ESPEN is an electronic-only journal and is an official publication of the European Society for Clinical Nutrition and Metabolism (ESPEN). Nutrition and nutritional care have gained wide clinical and scientific interest during the past decades. The increasing knowledge of metabolic disturbances and nutritional assessment in chronic and acute diseases has stimulated rapid advances in design, development and clinical application of nutritional support. The aims of ESPEN are to encourage the rapid diffusion of knowledge and its application in the field of clinical nutrition and metabolism. Published bimonthly, Clinical Nutrition ESPEN focuses on publishing articles on the relationship between nutrition and disease in the setting of basic science and clinical practice. Clinical Nutrition ESPEN is available to all members of ESPEN and to all subscribers of Clinical Nutrition.